First-line doxorubicin and high-dose ifosfamide (DHI) in advanced soft tissue sarcoma (STS) patients. A phase II study of the Spanish Group for Research on Sarcomas (GEIS)

被引：0
|
作者：
Lopez-Pousa, A [1 ]
Montalar, J [1 ]
Buesa, J [1 ]
Maurel, J [1 ]
Martin, J [1 ]
Cassinello, J [1 ]
Sevilla, I [1 ]
de las Penas, R [1 ]
Cruz, J [1 ]
Balana, C [1 ]
机构：
[1] Hosp Sant Pau, Spanish Grp Res Sarcomas, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
564P
引用
收藏
页码：117 / 117
页数：1
相关论文
共 50 条
  • [21] Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study
    Martin-Liberal, Juan
    Lopez-Pousa, Antonio
    Martinez-Trufero, Javier
    Martin-Broto, Javier
    Cubedo, Ricardo
    Lavernia, Javier
    Redondo, Andres
    Antonio Lopez-Martin, Jose
    Mulet-Margalef, Nuria
    Sanjuan, Xavier
    Tirado, Oscar M.
    Garcia-del-Muro, Xavier
    TARGETED ONCOLOGY, 2018, 13 (01) : 81 - 87
  • [22] Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study
    Juan Martin-Liberal
    Antonio López-Pousa
    Javier Martínez-Trufero
    Javier Martín-Broto
    Ricardo Cubedo
    Javier Lavernia
    Andrés Redondo
    José Antonio López-Martín
    Nùria Mulet-Margalef
    Xavier Sanjuan
    Òscar M. Tirado
    Xavier Garcia-del-Muro
    Targeted Oncology, 2018, 13 : 81 - 87
  • [23] HIGH-DOSE DTIC IN ADVANCED SOFT-TISSUE SARCOMAS (STS) OF THE ADULT - A PHASE-II STUDY OF THE EORTC SOFT-TISSUE AND BONE SARCOMA GROUP
    BUESA, JM
    MOURIDSEN, H
    VANOOSTEROM, AT
    STEWARD, WT
    VERWEY, J
    THOMAS, D
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 73 - 73
  • [24] Salvage surgical resection after high-dose ifosfamide (HDIF) based regimens in advanced soft tissue sarcoma (ASTS):: A potential positive selection bias -: A study of the Spanish Group for Research on Sarcomas (GEIS)
    Maurel, J
    Buesa, J
    López-Pousa, A
    Del Muro, XG
    Quintana, MJ
    Martín, J
    Casado, A
    Martínez-Trufero, J
    de las Peñas, R
    Balaña, C
    JOURNAL OF SURGICAL ONCOLOGY, 2004, 88 (01) : 44 - 49
  • [25] HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study
    Moura, David S.
    Mondaza-Hernandez, Jose L.
    Sanchez-Bustos, Paloma
    Pena-Chilet, Maria
    Cordero-Varela, Juan A.
    Lopez-Alvarez, Maria
    Carrillo-Garcia, Jaime
    Martin-Ruiz, Marta
    Romero-Gonzalez, Pablo
    Renshaw-Calderon, Marta
    Ramos, Rafael
    Marcilla, David
    Alvarez-Alegret, Ramiro
    Agra-Pujol, Carolina
    Izquierdo, Francisco
    Ortega-Medina, Luis
    Martin-Davila, Francisco
    Hernandez-Leon, Carmen Nieves
    Romagosa, Cleofe
    Salgado, Maria Angeles Vaz
    Lavernia, Javier
    Bague, Silvia
    Mayodormo-Aranda, Empar
    Alvarez, Rosa
    Valverde, Claudia
    Martinez-Trufero, Javier
    Castilla-Ramirez, Carolina
    Gutierrez, Antonio
    Dopazo, Joaquin
    Hindi, Nadia
    Garcia-Foncillas, Jesus
    Martin-Broto, Javier
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2024, 81 (01)
  • [26] Phase I/II study of docetaxel, ifosfamide, and doxorubicin in advanced, recurrent, or metastatic soft tissue sarcoma (STS)
    Revathi Suppiah
    Laura Wood
    Paul Elson
    George T. Budd
    Investigational New Drugs, 2006, 24 : 509 - 514
  • [27] A pilot study of first-line olaratumab, doxorubicin and ifosfamide in patients with metastatic soft tissue sarcoma
    Vornicova, Olga
    Haim, Nissim
    Bar-Sela, Gil
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (04) : 919 - 923
  • [28] A pilot study of first-line olaratumab, doxorubicin and ifosfamide in patients with metastatic soft tissue sarcoma
    Olga Vornicova
    Nissim Haim
    Gil Bar-Sela
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 919 - 923
  • [29] Phase I/II study of docetaxel, ifosfamide, and doxorubicin in advanced, recurrent, or metastatic soft tissue sarcoma (STS)
    Suppiah, Revathi
    Wood, Laura
    Elson, Paul
    Budd, George T.
    INVESTIGATIONAL NEW DRUGS, 2006, 24 (06) : 509 - 514
  • [30] Phase I/II study of docetaxel, ifosfamide, and doxorubicin in advanced, recurrent, or metastatic soft tissue sarcoma (STS).
    Suppiah, R
    Budd, GT
    Wood, L
    Elson, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 831S - 831S
12345